×
About 16,835 results

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
https://doi.org/10.1002/art.41752
Arthritis & Rheumatology (Hoboken, N.J.); Fraenkel L, Bathon JM et. al.

Jun 9th, 2021 - To develop updated guidelines for the pharmacologic management of rheumatoid arthritis. We developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions. After conducting a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to rate the certainty of evidence. A voting panel comprising c...

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Sy...
https://doi.org/10.1053/j.gastro.2022.04.016
Gastroenterology Chang L, Sultan S et. al.

Jun 24th, 2022 - Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction associated with significant disease burden. This American Gastroenterological Association guideline is intended to support practitioners in decisions about the use of medications for the pharmacological management of IBS-C and is an update of a prior technical review and guideline. The Grading of Recommendations Assess...

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Sy...
https://doi.org/10.1053/j.gastro.2022.04.017
Gastroenterology Lembo A, Sultan S et. al.

Jun 24th, 2022 - Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder associated with significant disease burden. This American Gastroenterological Association Guideline is intended to support practitioners in decisions about the use of medications for the pharmacological management of IBS with predominant diarrhea (IBS-D) and is an update of a prior technical review and guideline. Th...

ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT...
https://doi.org/10.1016/j.prro.2022.01.015
Practical Radiation Oncology; Damico N, Meyer J et. al.

Jun 19th, 2022 - Previous anal cancer guidelines delineate target volumes similarly for all patients with squamous cell carcinoma of the anal canal and/or perianal skin (SCCA), regardless of disease stage. The purpose of this guideline is to provide customized radiation treatment recommendations for early stage (T1-2 N0 M0) anal cancer treated with intensity modulated and image guided radiation therapy (RT). A ...

Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic ...
https://doi.org/10.1016/j.echo.2022.03.012
Journal of the American Society of Echocardiography : Off... Nagueh SF, Phelan D et. al.

Jun 7th, 2022 - Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular hypertrophy in the absence of other potentially causative cardiac, systemic, syndromic, or metabolic diseases. Symptoms can be related to a range of pathophysiologic mechanisms including left ventricular outflow tract obstruction with or without significant mitral regurgitation, diastolic dysfunction with heart fai...

Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Can...
https://doi.org/10.3390/curroncol29050257
Current Oncology (Toronto, Ont.); Mulder K, Lim H et. al.

May 28th, 2022 - Gastric, esophageal and gastro-esophageal junction cancers are associated with inferior outcomes. For early-stage disease, perioperative chemotherapy or chemoradiation followed by surgery is the standard treatment. For most patients with advanced upper gastrointestinal tract cancers, platinum-based chemotherapy remains a standard treatment. Recently, several randomized clinical trials have demo...

Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force...
https://doi.org/10.1001/jama.2022.7015
JAMA , Mangione CM et. al.

May 25th, 2022 - Impairment of visual acuity is a serious public health problem in older adults. The number of persons 60 years or older with impaired visual acuity (defined as best corrected visual acuity worse than 20/40 but better than 20/200) was estimated at 2.91 million in 2015, and the number who are blind (defined as best corrected visual acuity of 20/200 or worse) was estimated at 760 000. Impaired vis...

ACOG Practice Bulletin No. 147: Lynch Syndrome: Correction.
https://doi.org/10.1097/AOG.0000000000004736 10.1097/01.AOG.0000456325.50739.72
Obstetrics and Gynecology;

May 21st, 2022 - ACOG Practice Bulletin No. 147: Lynch Syndrome: Correction.|2022||diagnosis,therapy,

Management of Postmenopausal Osteoporosis: ACOG Clinical Practice Guideline No. 2.
https://doi.org/10.1097/AOG.0000000000004730 10.7326/M19-0533 10.1359/jbmr.061113 10.1097/AOG.0000000000004514 10.1097/AOG.0000000000004519 10.1136/bmj.39489.470347.AD 10.1016/j.jclinepi.2010.04.026 10.1016/j.jclinepi.2014.12.011 10.1001/jama.285.3.320 10.1210/jc.2019-00221 10.1001/archinte.163.17.2052 10.1089/jwh.2012.3812 10.1007/s11606-009-1031-8 10.1016/j.amjmed.2017.02.042 10.1111/jgs.16455 10.1097/AOG.0000000000002459 10.1177/0002764213487340 10.1146/annurev-publhealth-040218-043750 10.1007/s11606-007-0217-1 10.4158/GL-2020-0524SUPPL 10.1007/s00198-014-2794-2 10.6004/jnccn.2013.0215 10.1097/GME.0000000000000515 10.1007/s10549-019-05464-w 10.1200/JCO.19.01696 10.1001/jama.2018.6537 10.1001/jama.2018.7498 10.1210/jc.2019-00192 10.1016/j.bone.2019.115081 10.26355/eurrev_201903_17414 10.1210/clinem/dgaa048 10.1016/j.ijsu.2019.03.004 10.1016/j.maturitas.2019.08.003 10.1210/jc.2019-00193 10.4158/EP161678.RA 10.1016/j.bone.2013.09.023 10.1016/j.bonr.2020.100729 10.1056/NEJMoa1808082 10.1007/s00198-007-0493-y 10.1016/j.clinthera.2019.05.001 10.1007/s00198-009-0930-1 10.1002/jbmr.2708 10.1016/j.jacr.2017.02.018 10.1515/hmbci-2019-0021 10.1056/NEJMoa1916525 10.1001/jama.296.24.2927 10.1002/jbmr.1494 10.1016/S2213-8587(17)30138-9 10.11622/smedj.2019028 10.1210/jc.2018-01965 10.1002/jbmr.3337 10.1359/JBMR.050509 10.1001/jama.2019.5780 10.1097/GME.0000000000000619 10.1097/01.AOG.0000441353.20693.78 10.1001/jama.290.13.1729 10.1359/jbmr.060312 10.1097/01.gme.0000123641.76105.b5 10.1016/j.fertnstert.2009.02.093 10.1210/jc.2013-1707 10.1016/s0002-9343(00)00490-3 10.1016/j.bone.2018.10.015 10.1007/s11657-019-0564-7 10.1210/jc.2018-00163 10.1056/NEJMoa1607948 10.1080/13697137.2018.1433655 10.1056/NEJMoa1708322 10.1002/jbmr.3452 10.1007/s00198-019-05146-9 10.1210/jc.2003-030501 10.1007/s00198-018-4759-3 10.1007/s00198-018-4704-5 10.1007/s00198-015-3386-5 10.1007/s00198-016-3699-z 10.1001/jamanetworkopen.2019.17789 10.1001/jama.2017.21640 10.1097/gme.0b013e31821fc8e0 10.1080/13697137.2016.1238451 10.3945/ajcn.116.151464 10.1097/GME.0b013e3182896ae5 10.3945/jn.115.219238 10.1007/s00198-011-1577-2 10.1080/08952841.2018.1418822 10.3390/nu10010097 10.1097/GME.0000000000001831 10.1007/s11657-013-0167-7
Obstetrics and Gynecology;

May 21st, 2022 - To provide updated evidence-based recommendations for the treatment of postmenopausal osteoporosis. Postmenopausal patients with primary osteoporosis. This guideline was developed using an a priori protocol in conjunction with a writing team consisting of two specialists in obstetrics and gynecology appointed by the ACOG Committee on Clinical Practice Guidelines-Gynecology and one external subj...

ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate ...
https://doi.org/10.1097/COC.0000000000000915
American Journal of Clinical Oncology; Bittner NHJ, Cox BW et. al.

May 20th, 2022 - The American College of Radiology (ACR), American Brachytherapy Society (ABS), and American Society for Radiation Oncology (ASTRO) have jointly developed the following practice parameter for transperineal permanent brachytherapy of prostate cancer. Transperineal permanent brachytherapy of prostate cancer is the interstitial implantation of low-dose rate radioactive seeds into the prostate gland...

Guideline No. 422g: Menopause and Osteoporosis.
https://doi.org/10.1016/j.jogc.2021.09.013
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Khan AA, Alrob HA et. al.

May 17th, 2022 - Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence. Perimenopausal and postmenopausal women. Target population will benefit from the most recent published scientific evidence provided via the information from their health care provider. No harms or costs are involved with this information since women will have the opp...

Headaches in Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 3.
https://doi.org/10.1097/AOG.0000000000004766 10.1148/rg.2016150187 10.1016/S1474-4422(18)30322-3 10.1016/S0140-6736(20)30925-9 10.1186/s10194-020-01208-0 10.1212/01.wnl.0000252808.97649.21 10.1111/head.12150 10.1097/AOG.0000000000004519 10.1136/bmj.39489.470347 10.1016/j.jclinepi.2010.04.026 10.1016/j.jclinepi.2014.12.011 10.1177/0333102417738202 10.1152/physrev.00034.2015 10.1111/j.1526-4610.2006.00483.x 10.1007/s40265-018-0865-y 10.1212/wnl.25.3.239 10.1212/01.wnl.0000130338.62037.cc 10.1007/s10072-019-03792-9 10.1097/OGX.0000000000000738 10.1111/j.1468-2982.2008.01704.x 10.1111/j.1468-2982.2009.01935.x 10.11607/ofph.1869 10.1136/bmj.k80 10.1097/OGX.0000000000000540 10.1586/14737175.8.3.385 10.1111/ncn3.12322 10.1111/j.1526-4610.2009.01438.x 10.1097/NRL.0b013e3181663555 10.1097/AOG.0000000000004247 10.3390/ijerph18041503 10.1136/acupmed-2013-010480 10.4103/0973-7847.79105 10.1016/j.ejogrb.2019.07.021 10.1111/j.1526-4610.2011.02066.x 10.1186/s10194-017-0823-1 10.1007/s00415-018-8924-6 10.5505/agri.2018.85688 10.1016/j.emc.2016.06.014 10.1111/j.1468-1331.2011.03629.x 10.1111/j.1468-1331.2011.03562.x 10.1136/practneurol-2013-000664 10.1016/j.ajog.2007.01.034 10.1097/MAJ.0b013e31821e0e91 10.1111/head.13279 10.1007/s11910-019-0944-9 10.12891/ceog17052014 10.1111/j.1526-4610.2005.05012.x 10.3174/ajnr.A0506 10.1016/j.jacr.2019.05.030 10.1016/j.ncl.2019.09.001 10.1007/s11916-016-0585-5 10.5505/tbdhd.2014.74046 10.1001/jama.2016.12126 10.1097/AOG.0000000000002355 10.1016/j.ogc.2020.11.007 10.1161/STR.0000000000000211 10.1038/nrneurol.2009.100 10.1097/AOG.0000000000003891 10.1016/S1474-4422(12)70306-X 10.1016/j.ajog.2013.02.015 10.1136/bcr-2014-207332 10.1055/s-0037-1608940 10.1111/jog.12788 10.1016/S1474-4422(15)00111-8 10.1016/j.jogoh.2019.03.019 10.1007/s11739-017-1712-y 10.5530/jcdr.2016.2.7 10.1055/s-0038-1673681 10.1097/01.anes.0000282103.70955.c4 10.1111/j.1365-2044.2007.05285.x 10.1016/j.mpaic.2013.05.003 10.1213/ane.0000000000004336 10.1016/j.ijoa.2016.06.005 10.1016/j.jclinane.2011.04.003 10.1111/j.1399-6576.2005.00720.x 10.1007/s11845-019-02139-9 10.1213/ANE.0000000000004561 10.1016/j.mpaic.2019.06.003 10.1213/ane.0b013e3182501c06 10.1001/jamaneurol.2019.2995 10.1097/AAP.0000000000000455 10.1016/j.clineuro.2015.01.028 10.1016/j.jclinane.2014.07.008 10.1016/j.bja.2021.05.020 10.1111/anae.15491 10.1007/s11916-007-0024-8 10.1016/j.ajog.2006.09.044 10.1515/crpm-2015-0103 10.1097/NRL.0b013e318247bb59 10.1038/nrneurol.2009.114 10.1111/j.1526-4610.2011.01881.x 10.1007/s40618-014-0095-4 10.1530/EDM-14-0043 10.1177/1753495X15598917 10.1056/NEJMicm0900500 10.1136/bcr-2015-210198 10.1097/WNQ.0b013e31822df85a 10.1515/crpm-2019-0049 10.1056/NEJMcpc1501763 10.1213/01.ANE.0000072704.87018 10.1055/s-0038-1646952 10.1111/ppe.12595 10.3399/bjgp13X670895 10.1097/AOG.0b013e3181eeb2a1 10.1212/01.wnl.0000335946.53860.1d 10.1592/phco.22.12.1029.33595 10.1111/j.1468-2982.2004.00691.x 10.1046/j.1526-4610.2001.01189.x 10.1111/j.1526-4610.2011.02039.x 10.1016/j.ncl.2008.11.008 10.1046/j.1526-4610.1998.3807516.x 10.1016/j.pain.2014.08.009 10.1111/head.12208 10.1111/head.12203 10.1345/aph.1K176 10.1097/AOG.0000000000002235 10.1111/head.12835 10.1046/j.1526-4610.2001.111006171.x 10.1016/j.jemermed.2009.08.022 10.1016/j.annemergmed.2018.09.028 10.1177/0333102414566200 10.1097/AOG.0000000000004517 10.1111/head.12064 10.1111/bcpt.13579 10.1038/clpt.2008.157 10.1016/S0140-6736(06)69255-6 10.1016/j.ncl.2012.04.001 10.1016/j.ijoa.2006.08.015 10.1111/anae.12562 10.1136/rapm-2019-101053 10.1016/j.jclinane.2016.04.009 10.1111/head.13442 10.1016/j.ijoa.2016.10.010 10.1111/j.1399-6576.2010.02335.x 10.1097/AAP.0000000000000840 10.1016/j.jclinane.2014.03.006 10.1097/MD.0000000000028438 10.1016/j.ijoa.2018.12.006 10.1016/j.jocn.2017.02.046 10.1136/bcr-2013-009931 10.1016/j.ijoa.2021.103218 10.1097/AOG.0000000000002706 10.1097/AOG.0000000000002703 10.1097/01.AOG.0000423816.39542.0f 10.1001/jama.2021.7517 10.1136/practneurol-2016-001589 10.1155/2014/397131
Obstetrics and Gynecology;

May 17th, 2022 - To provide updated evidence-based recommendations for the evaluation and treatment of primary and secondary headaches in pregnancy and postpartum. Pregnant and postpartum patients with a history of or experiencing primary or new secondary headaches. This guideline was developed using an a priori protocol in conjunction with a writing team consisting of two specialists in obstetrics and gynecolo...

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diag...
https://doi.org/10.1016/j.eprac.2022.03.010
Endocrine Practice : Official Journal of the American Col... Cusi K, Isaacs S et. al.

May 16th, 2022 - To provide evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders. The American Association of Clinical Endocrinology conducted literature searches for relevant articles published from January 1, 2010, ...

ACR Appropriateness Criteria® Chronic Chest Pain-High Probability of Coronary Artery Di...
https://doi.org/10.1016/j.jacr.2022.02.021
Journal of the American College of Radiology : JACR; , Litmanovich D et. al.

May 14th, 2022 - Management of patients with chronic chest pain in the setting of high probability of coronary artery disease (CAD) relies heavily on imaging for determining or excluding presence and severity of myocardial ischemia, hibernation, scarring, and/or the presence, site, and severity of obstructive coronary lesions, as well as course of management and long-term prognosis. In patients with no known is...

ACR Appropriateness Criteria® Crohn Disease-Child.
https://doi.org/10.1016/j.jacr.2022.02.020
Journal of the American College of Radiology : JACR; , Moore MM et. al.

May 14th, 2022 - Crohn disease is an inflammatory condition of the gastrointestinal tract with episodes of exacerbation and remission occurring in children, adolescents, and adults. Crohn disease diagnosis and treatment depend upon a combination of clinical, laboratory, endoscopic, histological, and imaging findings. Appropriate use of imaging provides critical information in the settings of diagnosis, assessme...

Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease.
https://doi.org/10.1016/j.cjca.2022.02.029
The Canadian Journal of Cardiology; , Abramson BL et. al.

May 11th, 2022 - Patients with widespread atherosclerosis such as peripheral artery disease (PAD) have a high risk of cardiovascular and limb symptoms and complications, which affects their quality of life and longevity. Over the past 2 decades there have been substantial advances in diagnostics, pharmacotherapy, and interventions including endovascular and open surgical to aid in the management of PAD patients...

The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Pa...
https://doi.org/10.1097/JU.0000000000002767
The Journal of Urology; Bivalacqua TJ, Allen BK et. al.

May 11th, 2022 - Priapism is a persistent penile erection that continues hours beyond, or is unrelated to, sexual stimulation and results in a prolonged and uncontrolled erection. Given its time-dependent and progressive nature, priapism is a situation that both urologists and emergency medicine practitioners must be familiar with and comfortable managing. A comprehensive search of the literature on acute ische...

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radi...
https://doi.org/10.1097/JU.0000000000002759
The Journal of Urology; Eastham JA, Auffenberg GB et. al.

May 11th, 2022 - The summary presented herein represents Part III of the three-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of radiation and offering several future directions of further relevant study in patients diagnosed with clinically localized prostate cancer. Please refer to Parts I and II for discussion of risk assessment, staging, and risk-ba...

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk A...
https://doi.org/10.1097/JU.0000000000002757
The Journal of Urology; Eastham JA, Auffenberg GB et. al.

May 11th, 2022 - The summary presented herein represents Part I of the three-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment, staging, and risk-based management in patients diagnosed with clinically localized prostate cancer. Please refer to Parts II and III for discussion of principles of active surveillance, surgery and follow-up (Part II), and pr...

Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline.
https://doi.org/10.1016/j.prro.2022.02.003
Practical Radiation Oncology; Gondi V, Bauman G et. al.

May 10th, 2022 - This guideline provides updated evidence-based recommendations addressing recent developments in the management of patients with brain metastases, including advanced radiation therapy techniques such as stereotactic radiosurgery (SRS) and hippocampal avoidance whole brain radiation therapy and the emergence of systemic therapies with central nervous system activity. The American Society for Rad...